Concepedia

Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients

Carlos Camps, Carmen Sarries, Bárbara Roig, José Javier Sánchez, Cristina Queralt, Eva Sancho, Natividad Martínez-Banaclocha, Miguel Tarón, Rafael Rosell

Clinical Lung Cancer · 2003 · 54 citations · 23 references

DOI

Concepts

References

23

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

, , +14

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1998 · 510 citations

, , +10

Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study

Qingyi Wei · JNCI Journal of the National Cancer Institute · 2000 · 507 citations · Full text

, , +17

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.

M R Spitz, Xueyan Wu, Ying Wang et al. · PubMed · 2001 · 493 citations

, , +15

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

Meenakshi Dabholkar, Justine Vionnet, Jin‐Tai Yu et al. · Journal of Clinical Investigation · 1994 · 446 citations · Full text

, , +16